Evolus Inc buy stratec
Start price
20.05.19
/
50%
€14.97
Target price
24.10.20
€8.00
Performance (%)
-81.26%
End price
24.10.20
€2.81
Summary
This prediction ended on 24.10.20 with a price of €2.81. Massive losses of -81.26% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evolus Inc | 12.381% | 12.381% | 60.544% | 60.544% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by stratec for this prediction
In the thread Evolus Inc diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 20.05.2019 der Buy-Einschätzung von klostergang mit dem Kursziel 35$ zu.
Überschrift: Evolus obtained FDA approval for its product Jeuveau to treat patients with glabellar lines.
Es gibt keinen Handelsplatz
Kursziel geändert auf 8,0
In the thread Trading Evolus Inc
Buy beendet